What's Going On AbbVie Stock On Friday?

Published on 12 Apr 2024 on Benzinga via Yahoo Finance

What's Going On AbbVie Stock On Friday?

Friday, AbbVie Inc (NYSE:ABBV) released an interim analysis of an ongoing Phase 3, open-label 156-week extension study evaluating the long-term safety and tolerability of oral atogepant for the prevention of migraine in participants with chronic or episodic migraine.

The shares are trading lower with a session volume of 3.9 million versus the average volume of 5.6 million, as per the data from Benzinga Pro.

Read the rest of the article

NYSE.ABBV price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

What is an Annuity for Retirement? 15 Dividend Stocks to Buy Instead

In this article, we discuss what is an annuity for retirement and 15 dividend stocks to buy inste...

Insider Monkey via Yahoo Finance 28 Apr 2024

12 Under-the-Radar High Dividend Stocks to Invest in Now

In this article, we discuss 12 under-the-radar high dividend stocks to invest in now. You can ski...

Insider Monkey via Yahoo Finance 28 Apr 2024

AbbVie (ABBV) Beats on Q1 Earnings & Sales, Ups '24 EPS View

AbbVie Inc. ABBV reported adjusted earnings of $2.31 per share for first-quarter 2024, beating th...

Zacks via Yahoo Finance 26 Apr 2024

Cigna to offer Humira rivals with $0 copay at specialty pharmacy

Cigna plans to make close copies of AbbVie's blockbuster arthritis drug Humira available with no...

Reuters 25 Apr 2024

AbbVie Q1 Preview: Skyrizi and Rinvoq’s launches could help Q1 (NYSE:ABBV)

AbbVie (ABBV) is set to report Q1 earnings results on April 26th. Analysts expect a profit of $2....

Seeking Alpha 25 Apr 2024

What's in Store for These 5 Pharma Bigwigs in Q1 Earnings?

The first-quarter 2024 reporting cycle of the Medical sector is about to pick up pace this week. ...

Zacks via Yahoo Finance 24 Apr 2024

Should Pacer US Cash Cows 100 ETF (COWZ) Be on Your Investing Radar?

Launched on 12/16/2016, the Pacer US Cash Cows 100 ETF (COWZ) is a passively managed exchange tra...

Zacks via Yahoo Finance 23 Apr 2024

AbbVie (ABBV) to Report Q1 Earnings: What's in the Cards?

AbbVie ABBV will report first-quarter 2024 results on Apr 26, before market open. In the last rep...

Zacks via Yahoo Finance 22 Apr 2024

AbbVie stock gains as Rinvoq succeeds in giant cell arteritis

AbbVie (ABBV) stock gains as the company's JAK inhibitor, upadacitinib, succeeds in a Phase 3 tri...

Seeking Alpha 18 Apr 2024

AbbVie buyout Cerevel marks trial win for Parkinson’s drug

AbbVie's (ABBV) buyout target, Cerevel Therapeutics (CERE), announced positive data for its...

Seeking Alpha 18 Apr 2024

News

What's Going On AbbVie Stock On Friday?

NYSE.ABBV price evolution

Want to become a better investor?